Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
trastuzumab receptor tyrosine-protein kinase erbb-2 biotech NA drugbank , DGIDB Breast[MeSHID:D001940]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.89 approved,investigational binder,antibody
trastuzumab receptor tyrosine-protein kinase erbb-2 biotech NA drugbank , DGIDB Breast[MeSHID:D001940]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.89 approved,investigational binder,antibody,inhibitor
trastuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.89 approved inhibitor
trastuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.89 approved unknown
trastuzumab erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Breast[MeSHID:D001940]
Adenocarcinoma[MeSHID:D000230]
Stomach[MeSHID:D013270]
Neoplasm Metastasis[MeSHID:D009362]
Malignant neoplasm of breast[MeSHID:D001943]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.89 approved antibody
click here to return to the previous page